Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
about
Management of endocrine disease: Secondary osteoporosis: pathophysiology and managementImpact of antiepileptic drugs on bone health: Need for monitoring, treatment, and prevention strategiesNutritional Aspects of Treatment in Epileptic PatientsInfluence of season, ethnicity, and chronicity on vitamin D deficiency in traumatic spinal cord injury.Antiepileptic drugs and bone metabolism in children: data from 128 patients.Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI)Effects of carbamazepine on serum parathormone, 25- hydroxyvitamin D, bone specific alkaline phosphatase, C-telopeptide, and osteocalcin levels in healthy ratsOsteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.Antiepileptics and bone health.Induction of endogenous pathways by antiepileptics and clinical implications.Greater Calcium Intake is Associated with Better Bone Health Measured by Quantitative Ultrasound of the Phalanges in Pediatric Patients Treated with Anticonvulsant DrugsQuadriplegia Following Epileptic Seizure : Things to Keep in Mind.When should clinicians worry about bone density for patients with epilepsy?Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report.Evidence-based review of bone strength in children and youth with cerebral palsy.Possible methods for the prevention of bone loss in persons with epilepsy.Fracture risk assessment in postmenopausal women.Bone loss associated with use of antiepileptic drugs.Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.The long-term safety of antiepileptic drugs.The problem of osteoporosis in epileptic patients taking antiepileptic drugs.Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.The antiepileptic medications carbamazepine and phenytoin inhibit native sodium currents in murine osteoblasts.Epilepsy, culture, identity and well-being: a study of the social, cultural and environmental context of epilepsy in Cameroon.Bone mineral density in ambulatory children with epilepsy.
P2860
Q26998249-761FB6AC-6FAA-44E9-81D4-F6D9FEAEF998Q28074005-5C40ADD8-5DC6-4811-AA95-239E8CEC57D5Q28079443-A7AE8E3F-429E-4757-AE0E-EF4BDDB471D5Q34060129-5D9700F2-A6C2-4E64-B843-F9D75F6B5BCAQ34253275-C01AAD9D-C368-4311-AEEC-F7E05CDEDDFCQ35156078-F73144CA-E54E-471D-B29F-4ED05B394F8AQ35184525-27BC0297-B3E6-4777-9319-6DE13B886A59Q35924416-6F15C358-9116-4EBC-A3EC-9EE18E9C070FQ36007883-38934F12-2B43-4476-92A2-AC29EE5001F7Q36059549-B25BE31E-0DCA-463A-92E6-1D63891D6488Q36263605-F9D0696D-BAD6-44E9-919D-D72386A9F7C4Q36401278-5830F0AB-5450-42AF-9DD5-530305212845Q36928413-495C1BCA-8F92-4A58-BD67-460150E866A2Q37029081-9783BB44-4E4A-43E4-8968-2D46D444F3ADQ37178973-3D05E59F-51BA-46B5-83BD-FE3F965BE61AQ37338208-D84C4112-9509-44FD-9096-EBCBD7D531D9Q37423494-881DA616-880F-497C-A633-CCF18F39843CQ37507951-4E3161E8-F99A-4743-9F40-56DA4D1D5892Q37607122-459E0869-79F4-4917-A5F4-BC323D763CE7Q37702229-E5895291-1952-49AA-91A6-82AFB53267A0Q37990836-4F352CF5-50FF-4112-AF95-F609D4934E8CQ38106856-CDBE21CA-A3EF-4CD9-89CB-687BB9AC62CAQ38211406-F527ADAF-4E98-4BEE-B054-3E06D4DF74B8Q46313804-47EC3B70-368E-4564-95F1-D141328E2DD3Q47406646-DB6E0A41-D86F-4416-9D68-BE5E67205406Q47794048-33651D54-CC15-467A-AA3D-38789E7AE13CQ51059654-B2B2C4A4-990A-4685-82AB-D1E0A5DFB48C
P2860
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@en
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@nl
type
label
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@en
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@nl
prefLabel
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@en
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@nl
P1433
P1476
Pathophysiology of bone loss in patients receiving anticonvulsant therapy.
@en
P2093
Lorraine A Fitzpatrick
P356
10.1016/J.YEBEH.2003.11.026
P478
P577
2004-02-01T00:00:00Z